Memorial Sloan Kettering Cancer Center:企業のM&A・事業提携・投資動向

◆英語タイトル:Memorial Sloan Kettering Cancer Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2025
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:151
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Memorial Sloan Kettering Cancer Center – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Memorial Sloan Kettering Cancer Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Memorial Sloan Kettering Cancer Center since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Memorial Sloan Kettering Cancer Center’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Memorial Sloan Kettering Cancer Center. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Memorial Sloan Kettering Cancer Center’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Memorial Sloan Kettering Cancer Center and its subsidiaries since 2007.
- Information about key financial and legal advisors for Memorial Sloan Kettering Cancer Center’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Memorial Sloan Kettering Cancer Center’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
CORPORATE VENTURING 7
Corporate Venturing – Overview 7
Corporate Venturing – Deal reports 8
PARTNERSHIP 17
Partnership – Overview 17
Partnership – Deal reports 18
APPENDIX 141
Contact Us 141
About MarketLine Financial Deals Database 141
Deal Definition and Methodology 143
About MarketLine 150

List of Tables
Table 1: Memorial Sloan Kettering Cancer Center corporate venturing volume and value trend (2014-YTD2018)
Table 2: Memorial Sloan Kettering Cancer Center corporate venturing by geography (2014-YTD2018)
Table 3: Memorial Sloan Kettering Cancer Center partnership volume and value trend (2014-YTD2018)
Table 4: Memorial Sloan Kettering Cancer Center partnership trend by key deal type (2014-YTD2018)

List of Figures
Figure 1: Memorial Sloan Kettering Cancer Center corporate venturing volume and value trend (2014-YTD2018)
Figure 2: Memorial Sloan Kettering Cancer Center corporate venturing by geography (2014-YTD2018)
Figure 3: Memorial Sloan Kettering Cancer Center partnership volume and value trend (2014-YTD2018)
Figure 4: Memorial Sloan Kettering Cancer Center partnership trend by key deal type (2014-YTD2018)

★海外企業調査レポート[Memorial Sloan Kettering Cancer Center:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Louisiana-Pacific Corporation:戦略・SWOT・企業財務分析
    Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Catabasis Pharmaceuticals Inc (CATB):製薬・医療:M&Aディール及び事業提携情報
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • Tempo Beverages Ltd.:企業の戦略・SWOT・財務情報
    Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bechtel Power Corporation:企業の戦略的SWOT分析
    Bechtel Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Respira Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Respira Therapeutics Inc (Respira) is a pharmaceutical development company that develops dry powder inhaler technologies. The company develops Inhaler technologies to enable targeted lung delivery of drugs to treat pulmonary diseases. It develops products used for the treatment of pulmonary …
  • Magellan Midstream Partners LP (MMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Magellan Midstream Partners LP (Magellan Midstream) is a midstream energy company. It transports, stores, and distributes refined petroleum products and crude oil. The company handles various petroleum products such as gasoline, diesel fuel, and crude oil. Magellan Midstream owns and operate …
  • CytomX Therapeutics Inc (CTMX):企業の財務・戦略的SWOT分析
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …
  • Genesis Energy:企業の戦略・SWOT・財務情報
    Genesis Energy - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • AviAlliance GmbH:企業の戦略・SWOT・財務情報
    AviAlliance GmbH - Strategy, SWOT and Corporate Finance Report Summary AviAlliance GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tarveda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarveda Therapeutics Inc (Tarveda), formerly Blend Therapeutics Inc is a clinical stage biopharmaceutical company that discovers and develops miniaturized novel biologic drug conjugates. The company develops targeted anti-cancer medicines for advancing the treatment for solid tumors. Its pip …
  • Electrocomponents plc (ECM):企業の財務・戦略的SWOT分析
    Electrocomponents plc (ECM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tahoe Resources Inc.:企業の戦略・SWOT・財務情報
    Tahoe Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Tahoe Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Freestone Resources Inc (FSNR):企業の財務・戦略的SWOT分析
    Summary Freestone Resources Inc (Freestone Resources) is an oilfield technology company that offers unconventional and conventional oil recovery solutions. The company offers petrozene solvent. Its petrozene solvent offers solutions in operations of tanker sludge, sediment and water, tar residue and …
  • Bavarian Nordic AS (BAVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology company that develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. The company develops its products using poxvirus-based technology platforms including vaccinia-fowlpox (VF)-TRICOM and …
  • Long Run Exploration Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Long Run Exploration Ltd (Long Run), formerly WestFire Energy Ltd, a subsidiary of Calgary Sinoenergy Investment Corp, is an oil and gas company that offers development and exploration of light oil. The company grows crude oil volumes within its diversified portfolio properties. Its oil expl …
  • Schweiter Technologies AG (SWTQ):企業の財務・戦略的SWOT分析
    Summary Schweiter Technologies AG (Schweiter) is a technology company that develops, manufactures and commercialize composite panels and core materials for sandwich constructions. The company’s business category includes core materials, architecture, display and transportation. It SSM textile machin …
  • Holland America Line Inc:企業の戦略的SWOT分析
    Holland America Line Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • NOW Inc (DNOW):企業の財務・戦略的SWOT分析
    NOW Inc (DNOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Taita Chemical Co Ltd (1309):企業の財務・戦略的SWOT分析
    Taita Chemical Co Ltd (1309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AddLife AB (ALIF B):医療機器:M&Aディール及び事業提携情報
    Summary AddLife AB (AddLife) is a medical device company. The company operates in business areas such as Labtech and Medtech. Its Labtech business offers products in various categories including hematology, pathology, POC, cellular biology, analytical instruments, consumables, advanced instruments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆